Table 2.

Potential predictors of adrenal suppression

	No AS	AS	p value
Female sex (N,  %)	3/10 (30 %)	4/19 (21.1 %)	0.66a
Age (median, IQR)	15.15 (4.75)	13.81 (4.66)	0.31b
Duration of GC therapy (days)	113.5 ± 30.44	99.8 ± 18.44	0.22c
BMI	18.2 ± 2.54	19.3 ± 3.15	0.33c
Concurrent use of ICS therapy (intermittent or continuous)	2/10 (20 %)	9/19 (47.3 %)	0.23a
Concurrent use of ICS therapy (continuous only)	1/10 (10 %)	5/19 (26.3 %)	0.63a

AS adrenal suppression, BMI body mass index, GC glucocorticoid, ICS inhaled corticosteroids, IQR interquartile range, N number

^aFisher’s Exact test

^bWilcoxon-Mann–Whitney test

^cT test (equal variances not assumed)